|
SMEK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.560220E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.219500E-03 |
| Normal-vs-Stage2 |
5.388500E-02 |
| Normal-vs-Stage3 |
1.123730E-02 |
| Normal-vs-Stage4 |
9.816500E-03 |
| Stage1-vs-Stage2 |
9.956400E-01 |
| Stage1-vs-Stage3 |
8.587800E-01 |
| Stage1-vs-Stage4 |
6.170200E-01 |
| Stage2-vs-Stage3 |
8.981800E-01 |
| Stage2-vs-Stage4 |
6.556600E-01 |
| Stage3-vs-Stage4 |
6.969400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.352400E-04 |
| Normal-vs-AfricanAmerican |
2.774200E-02 |
| Normal-vs-Asian |
5.905000E-01 |
| Caucasian-vs-AfricanAmerican |
4.857000E-01 |
| Caucasian-vs-Asian |
4.082200E-01 |
| AfricanAmerican-vs-Asian |
5.818800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.432000E-04 |
| Normal-vs-Female |
6.610100E-02 |
| Male-vs-Female |
3.166800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.163300E-03 |
| Normal-vs-Extreme_Weight |
8.047800E-04 |
| Normal-vs-Obese |
5.970300E-02 |
| Normal-vs-Extreme_Obese |
3.988100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.603600E-01 |
| Normal_Weight-vs-Obese |
2.597400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.823800E-01 |
| Extreme_Weight-vs-Obese |
1.394580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.377600E-01 |
| Obese-vs-Extreme_Obese |
4.790800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.842600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.810300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.13199999999203E-05 |
| Normal-vs-Age(81-100Yrs) |
7.159700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.305400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.962300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.200000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.497100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.271600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.843000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.789600E-02 |
| Normal-VS-Type2 PRCC |
1.51431999999563E-05 |
| Normal-VS-KIRP CIMP |
3.686800E-01 |
| Normal-VS-Unclassified PRCC |
6.995700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.170700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.610000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.872000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.407200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.520400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.645800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02819999999271E-05 |
| Normal-vs-N1 |
3.923600E-01 |
| Normal-vs-N2 |
2.628200E-04 |
| N0-vs-N1 |
1.537850E-02 |
| N0-vs-N2 |
1.049850E-01 |
| N1-vs-N2 |
3.795700E-02 |
|
|
